2nd Idiopathic Pulmonary Fibrosis (IPF) Summit 2018

2nd Idiopathic Pulmonary Fibrosis (IPF) Summit is organized by Hanson Wade and will be held from Aug 20 - 22, 2018 at The Marker San Francisco, San Francisco, California, United States of America.

With the incredible breakthrough success of drugs now in our arsenal for slowing IPF disease progression, the increasing importance of identifying genetic mechanisms, closing the translational gap between preclinical and clinical results, and developing candidates to reverse fibrosis have opened up further challenges within IPF drug development.

Built with Boehringer Ingelheim, Genentech, GSK, Bristol Myers Squibb, and Celgene: the IPF Summit is the definitive, industry dedicated networking and discussion forum exclusively focused on helping you overcome the translational challenges associated with the development of disease modifying IPF therapeutics.

Time: 8:50 am to 5:00 pm

Prices:
Early Bird by May 18: USD 2499.0,
Early Bird by June 15: USD 2599.0,
Early Bird by July 13: USD 2699.0,
Standard Price: USD 2799.0

Speakers: Gerald Nabozny (Boehringer Ingelheim), Joe Arron (Genentech), Fernando Martinez (Weill Cornell Medical College), Timothy Blackwell (Vanderbilt University Medical Center), Jan De Backer (FLUIDDA)

Additional details will be posted as soon as they are available.